Dose modifications of mezigdomide when coadministered with CYP3A4 inhibitors for patients with relapsed/refractory multiple myeloma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Yizhe Chen, Caroline Sychterz, Yiming Cheng, Shudi Li, Ekta Baranwal, Tiziana Civardi, Erica Petrlik, Aziz Khan, Jessica Katz
Institution: Bristol-Myers Squibb (Switzerland)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108476258
Cites:
Cited by:
Related to: